PARI Respiratory Products, a worldwide developer and manufacturer of aerosol delivery methods, received a 2015 American Deal Style Award for Kitabis Pak®.
Kitabis Pak, authorized by the Food and drug administration last December, is reportedly the very first co-packaging of generic tobramycin inhalation remedy with a PARI LC PLUS® Nebulizer for individuals with cystic fibrosis.
“This award highlights all the hard get the job done we set into this exceptional product or service giving of nebulized drug and product,” suggests Jan Zimmermann, Portfolio Manager for Kitabis Pak. “In developing a deal that is easy for people to use, we also required to express that the elements accommodate each and every other. By utilizing complimentary colors, the packaging visually demonstrates the reality that tobramycin inhalation solution was intended to be delivered by the PARI LC Furthermore Nebulizer.”
“Not only is the packaging beautiful, it makes sure that with every single prescription, every single affected person has accessibility to the only Food and drug administration-authorized nebulizer handset for tobramycin inhalation remedy and the same nebulizer utilised in scientific trials. It is gratifying that the inventive offer for this significant mix of therapy and delivery unit puts us along with other design and style winners, this sort of as Focus on, Burt’s Bees, Revlon, and Tory Burch,” says Ashley Weigand, Director of Marketing for PARI Respiratory Tools.
PARI Respiratory Tools completely markets Kitabis Pak and the compressor obtain plan named PARI Offer. Kitabis Pak is a new regular for nebulized medications very similar to bronchial asthma & COPD inhalers exactly where the drug and gadget are prescribed and dispensed with each other. PARI Offer takes the method one action further by giving patients with the only Fda-authorized compressor to deliver tobramycin inhalation remedy.